Literature DB >> 17056293

Rheumatologic manifestations of chronic hepatitis C infection.

Christian Lormeau1, Géraldine Falgarone, Dominique Roulot, Marie-Christophe Boissier.   

Abstract

The many rheumatologic manifestations associated with chronic hepatitis C virus (HCV) infection include arthralgia, myalgia, arthritis, vasculitis, and sicca syndrome. Arthralgia is the most common extrahepatic manifestation and may indicate mixed cryoglobulinemia or an adverse reaction to interferon therapy. HCV arthritis unrelated to cryoglobulinemia is far less common but constitutes an independent entity. The picture may mimic rheumatoid arthritis (RA), particularly as rheumatoid factor is present in 50-80% of cases. Tests are usually negative for antibodies to cyclic citrullinated peptides (anti-CCP), which may help to differentiate the two conditions. The management of HCV arthritis is empirical and poorly standardized. Although low-dose glucocorticoid therapy, hydroxychloroquine, and methotrexate have been used successfully in several patients, little is known about their hepatic safety profile. Arthritis associated with cryoglobulinemia usually responds to antiviral treatment. Sicca syndrome is common in patients with chronic HCV infection and shares similarities with primary Sjögren syndrome, suggesting that HCV infection may deserve to be included among the causes of secondary Sjögren syndrome. HCV-associated vasculitis is usually related to cryoglobulinemia, although a few cases of polyarteritis nodosa-like disease affecting the medium-sized vessels have been reported. Other conditions reported in patients with chronic HCV infection include fibromyalgia, systemic lupus erythematosus (SLE), antiphospholipid syndrome, and osteosclerosis.

Entities:  

Mesh:

Year:  2006        PMID: 17056293     DOI: 10.1016/j.jbspin.2006.05.005

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  19 in total

Review 1.  Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.

Authors:  Deng-Ho Yang; Ling-Jun Ho; Jenn-Haung Lai
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 2.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

3.  Hepatitis C virus infection and its rheumatologic implications.

Authors:  Zeynel A Sayiner; Uzma Haque; Mohammad U Malik; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-05

4.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

5.  Anti-cyclic citrullinated Peptide frequency in patients with chronic hepatitis C virus infection and effect of presence of systemic disease.

Authors:  Ayse Albayrak; Hakan Dursun; Muhammet Hamidullah Uyanik; Serkan Cerrah
Journal:  Eurasian J Med       Date:  2012-12

6.  Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

Authors:  Reem Hamdy Abdellatif Mohammed; Hesham Ibrahim ElMakhzangy; Amira Gamal; Fatma Mekky; Mohammed El Kassas; Nabil Mohammed; Mohammed Abdel Hamid; Gamal Esmat
Journal:  Clin Rheumatol       Date:  2010-04-22       Impact factor: 2.980

7.  Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.

Authors:  Diana V Stefanova-Petrova; Anelia H Tzvetanska; Elisaveta J Naumova; Anastasia P Mihailova; Evgenii A Hadjiev; Rumiana P Dikova; Mircho I Vukov; Konstantin G Tchernev
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

8.  Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver.

Authors:  Ali Aydeniz; M Namiduru; I Karaoglan; O Altindag; E Yagiz; S Gursoy
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

9.  Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.

Authors:  Amer Awad; Olaf Stüve; Marlyn Mayo; Rafeed Alkawadri; Bachir Estephan
Journal:  Case Rep Neurol Med       Date:  2011-07-10

Review 10.  Current treatment of hepatitis C-associated rheumatic diseases.

Authors:  Clodoveo Ferri; Marco Sebastiani; Alessandro Antonelli; Michele Colaci; A Manfredi; Dilia Giuggioli
Journal:  Arthritis Res Ther       Date:  2012-06-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.